The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker...

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Prostate cancer presents a significant challenge due to unpredictable disease progression, ranging from indolent to aggressive forms.
• Current clinical management is hampered by a lack of reliable biomarkers for risk stratification, therapy response, and outcome prediction.
• Cell adhesion to the extracellular matrix (ECM) via integrins plays a critical role in cancer cell behavior and fate.

Purpose of the Study:

• To review the biomarker potential of extracellular matrix (ECM) and integrin adhesion complex (IAC) related molecules in prostate cancer.
• To explore the role of these molecules in key cancer processes like tumor stiffening, bone turnover, and exosome-mediated communication.
• To identify novel biomarkers for improved prostate cancer diagnosis, prognosis, and treatment monitoring.

Main Methods:

• Literature review focusing on ECM and IAC molecules in prostate cancer.
• Analysis of studies investigating these molecules in body fluids and tumor tissue.
• Examination of the functional roles of ECM and IAC components in prostate cancer progression.

Main Results:

• ECM and IAC molecules are implicated in critical processes influencing prostate cancer aggressiveness.
• These molecules are found in body fluids and tissues, suggesting potential for detection.
• Processes such as tumor stiffening, bone remodeling, and exosome signaling involve ECM/IAC components and offer biomarker avenues.

Conclusions:

• ECM and IAC-related molecules hold significant promise as novel biomarkers for prostate cancer.
• Further research into these molecules could lead to improved clinical tools for patient management.
• Targeting ECM- and IAC-related pathways may offer new therapeutic strategies for aggressive prostate cancer.